Literature DB >> 7747757

Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region.

R E Nickel1, D A Pillers, M Merkens, R E Magenis, D A Driscoll, B S Emanuel, J Zonana.   

Abstract

Approximately 5% of children with neural tube defects (NTDs) have a congenital heart defect and/or cleft lip and palate. The cause of isolated meningomyelocele, congenital heart defects, or cleft lip and palate has been largely thought to be multifactorial. However, chromosomal, teratogenic, and single gene causes of combinations of NTDs with congenital heart defects and/or cleft lip and palate have been reported. We report on 3 patients with meningomyelocele, congenital heart defects, and 22q11 deletions. Two of the children had the clinical diagnosis of velo-cardio-facial syndrome (VCFS); both also have bifid uvula. The third child had DiGeorge sequence (DGS). The association of NTDs with 22q11 deletions has not been reported previously. An accurate diagnosis of the 22q11 deletion is critical as this micro-deletion and its associated clinical problems is transmitted as an autosomal dominant trait due to the inheritance of the deletion-bearing chromosome. We recommend that all children with NTDs and congenital heart defects, with or without cleft palate, have cytogenetic and molecular studies performed to detect 22q11 deletions.

Entities:  

Mesh:

Year:  1994        PMID: 7747757     DOI: 10.1002/ajmg.1320520410

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  14 in total

Review 1.  Velocardiofacial syndrome.

Authors:  A C Pike; M Super
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

2.  Monozygotic twins with chromosome 22q11 deletion and discordant phenotype.

Authors:  E Hatchwell
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

3.  Radial aplasia and chromosome 22q11 deletion.

Authors:  M C Digilio; A Giannotti; B Marino; A M Guadagni; M Orzalesi; B Dallapiccola
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

4.  Neural tube defects and atypical deletion on 22q11.2.

Authors:  Chiara Leoni; David A Stevenson; Katherine B Geiersbach; Christian N Paxton; Bryan L Krock; Rong Mao; Alan F Rope
Journal:  Am J Med Genet A       Date:  2014-08-13       Impact factor: 2.802

Review 5.  22q11 deletion syndrome: a genetic subtype of schizophrenia.

Authors:  A S Bassett; E W Chow
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

6.  Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia.

Authors:  E W Chow; D J Mikulis; R B Zipursky; L E Scutt; R Weksberg; A S Bassett
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

7.  Idiopathic hypoparathyroidism in two patients with 22q11 microdeletion.

Authors:  Y Makita; M Masuno; K Maizumi; K Tachibana; Y Kuroki; H Kurahashi
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

8.  Expanding the fetal phenotype: Prenatal sonographic findings and perinatal outcomes in a cohort of patients with a confirmed 22q11.2 deletion syndrome.

Authors:  Erica Schindewolf; Nahla Khalek; Mark P Johnson; Juliana Gebb; Beverly Coleman; Terrence Blaine Crowley; Elaine H Zackai; Donna M McDonald-McGinn; Julie S Moldenhauer
Journal:  Am J Med Genet A       Date:  2018-07-28       Impact factor: 2.802

9.  The 22q11.2 deletion in African-American patients: an underdiagnosed population?

Authors:  Donna M McDonald-McGinn; Nancy Minugh-Purvis; Richard E Kirschner; Abbas Jawad; Melissa K Tonnesen; Jason R Catanzaro; Elizabeth Goldmuntz; Deborah Driscoll; Don Larossa; Beverly S Emanuel; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2005-04-30       Impact factor: 2.802

10.  Prenatal SNP array testing in 1000 fetuses with ultrasound anomalies: causative, unexpected and susceptibility CNVs.

Authors:  Malgorzata I Srebniak; Karin Em Diderich; Marieke Joosten; Lutgarde Cp Govaerts; Jeroen Knijnenburg; Femke At de Vries; Marjan Boter; Debora Lont; Maarten Fcm Knapen; Merel C de Wit; Attie Tji Go; Robert-Jan H Galjaard; Diane Van Opstal
Journal:  Eur J Hum Genet       Date:  2015-09-02       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.